Friday, March 14, 2025

Creating liberating content

Oracle Corp’s (NYSE: ORCL)...

Oracle Corp (NYSE: ORCL) falls down to its knees, share dropped over 12.15%...

RTX Corp (NYSE: RTX)...

RTX Corp (NYSE: RTX) experienced a notable decline of -7.22%, amounting to $6.03...

GameStop Corp. (NYSE:GME) Quarter...

GameStop Corp. (NYSE: GME) to announce its second quarter fiscal 2023 results after...

Advanced Micro Devices (NASDAQ:AMD)...

Shares of Advanced Micro Devices (NASDAQ:AMD) drops 0.38% in afterhours in last trading...
HomeBiotech-PharmaDexCom, Inc. (NASDAQ:...

DexCom, Inc. (NASDAQ: DXCM) Intends to Releases CGM System New Zealand and South Africa In The Coming Weeks

DexCom, Inc. (Nasdaq: DXCM) surged in pre trading session and share rose around 7.5% in last session as the firm have live-streaming launch event gave an inside look at Dexcom G7 via the eyes of corporate executives, the G7 project team, and Dexcom Warriors from across the world. The new CGM system will also be available in New Zealand and South Africa in the coming weeks, with further markets to follow.

DexCom, Inc. (DXCM) recently announced that the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now available in the UK, Ireland, Germany, Austria, and Hong Kong for people with diabetes aged two years and older, marking the first major milestone in the availability of the revolutionary new technology. In addition, the business is moving fast to launch G7 in New Zealand and South Africa in the next weeks, with more countries to follow soon after.

The shares of firm have risen about 2,300% in the last decade, outperforming the S&P 500’s 170% and the Zacks Medical Products Market’s 25%. This run contains sideways movement as well as drops. DXCM’s outperformance has been consistent throughout the last five years. As previously stated, the stock had fallen from its November 2021 highs, as had practically every other growth-oriented firm.

Chairman, president and CEO of Dexcom, Kevin Sayer stated that since the release of the Dexcom G6, they have reduced over 15 billion fingerpricks and helped improve the lives of over 1.25 million diabetics worldwide. They’re ecstatic to kick off the global deployment of Dexcom G7, their next-generation CGM technology that substantially improves on what everyone loved about G6. Dexcom CGM has established the gold standard of diabetes treatment, and spreading their technology to more patients across the world remains a primary objective. With this initial launch behind them, they are looking forward to launching G7 in more areas and reaching as many people as possible with this life-changing technology.

Dexcom conducted a worldwide livestream launch event earlier today to announce the highly anticipated new gadget, G7, and included first-hand experiences from Dexcom Warriors from across the world sharing how Dexcom CGM has improved their life.

Oracle Corp’s (NYSE: ORCL) Cloud Business Faces Headwinds: What Lies Ahead

Oracle Corp (NYSE: ORCL) falls down to its knees, share dropped over 12.15% or $15.21 to trade at $111.50 in pre trading session on...

RTX Corp (NYSE: RTX) Updates 2023-2025 Outlook amid Engine Part Challenge

RTX Corp (NYSE: RTX) experienced a notable decline of -7.22%, amounting to $6.03 per share, bringing its current trading price to $77.45. The company,...

GameStop Corp. (NYSE:GME) Quarter Report: Resilience amidst Market Turbulence

GameStop Corp. (NYSE: GME) to announce its second quarter fiscal 2023 results after the market closes today. Shares were slightly down in the pre-trading...

Continue reading

RTX Corp (NYSE: RTX) Updates 2023-2025 Outlook amid Engine Part Challenge

RTX Corp (NYSE: RTX) experienced a notable decline of -7.22%, amounting to $6.03 per share, bringing its current trading price to $77.45. The company, with a substantial market capitalization of $112.57 billion, has seen its shares trade within a...

GameStop Corp. (NYSE:GME) Quarter Report: Resilience amidst Market Turbulence

GameStop Corp. (NYSE: GME) to announce its second quarter fiscal 2023 results after the market closes today. Shares were slightly down in the pre-trading session on Wednesday, September 6, 2023. Investors and market aficionados were eagerly awaiting the tech company's...

Nikola Corp. (NASDAQ: NKLA) Hit by Active Sellers on Profit in ‘Short Squeeze’

Shares of Nikola Corp. (NASDAQ: NKLA) drops in early trading session on Monday as the cutting into paper earnings for traders betting against the electric-vehicle company and setting them up for a short squeeze. According to S3 Partners LLC statistics,...

Enjoy exclusive access to all of our content

Get an online subscription and you can unlock any article you come across.